Published in Neoplasia on July 01, 2012
Ursolic acid simultaneously targets multiple signaling pathways to suppress proliferation and induce apoptosis in colon cancer cells. PLoS One (2013) 0.91
Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration. Neoplasia (2012) 0.89
Aspirin in combination with TACE in treatment of unresectable HCC: a matched-pairs analysis. Am J Cancer Res (2016) 0.82
Characterization of the inflammatory microenvironment and identification of potential therapeutic targets in wilms tumors. Transl Oncol (2014) 0.81
Poly-γ-glutamic acid induces apoptosis via reduction of COX-2 expression in TPA-induced HT-29 human colorectal cancer cells. Int J Mol Sci (2015) 0.79
Cancer subclonal genetic architecture as a key to personalized medicine. Neoplasia (2013) 0.78
Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27. J Vet Med Sci (2016) 0.77
Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis. Oncotarget (2016) 0.77
Expression of COX-2 and HER-2 in colorectal cancer and their correlation. World J Gastroenterol (2015) 0.75
Calcium Alginate and Calcium Alginate-Chitosan Beads Containing Celecoxib Solubilized in a Self-Emulsifying Phase. Scientifica (Cairo) (2016) 0.75
Induction of apurinic endonuclease 1 overexpression by endoplasmic reticulum stress in hepatoma cells. Int J Mol Sci (2014) 0.75
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology (1994) 8.79
Aspirin use and reduced risk of fatal colon cancer. N Engl J Med (1991) 7.85
Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study. J Clin Oncol (2007) 7.67
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med (2000) 7.54
Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell (1996) 7.46
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med (2003) 6.99
Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med (1994) 5.42
Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Natl Cancer Inst (1998) 2.26
Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J Natl Cancer Inst (1998) 2.09
Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line. J Biol Chem (2002) 1.63
Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy. J Clin Invest (2005) 1.58
Increased toxicity and lack of efficacy of Rofecoxib in combination with chemotherapy for treatment of metastatic colorectal cancer: A phase II study. Int J Cancer (2003) 1.43
Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice. Cancer Res (2003) 1.38
Cyclooxygenase-2 inhibition with celecoxib enhances antitumor efficacy and reduces diarrhea side effect of CPT-11. Cancer Res (2002) 1.26
Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer. Clin Cancer Res (2005) 1.25
COX-2-dependent stabilization of survivin in non-small cell lung cancer. FASEB J (2003) 1.24
Evidence for colorectal cancer cell specificity of aspirin effects on NF kappa B signalling and apoptosis. Br J Cancer (2004) 1.24
Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells. Breast Cancer Res (2005) 1.21
In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems. Cancer Chemother Pharmacol (1998) 1.15
Overexpression of the wild-type p53 gene inhibits NF-kappaB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells. Oncogene (2000) 1.10
A novel interaction between procaspase 8 and SPARC enhances apoptosis and potentiates chemotherapy sensitivity in colorectal cancers. J Biol Chem (2007) 1.06
COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer. Carcinogenesis (2011) 1.05
Five-year analysis of the prevention of colorectal sporadic adenomatous polyps trial. Am J Gastroenterol (2011) 1.04
Yes, but do they still get headaches? Cell (1995) 1.03
NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines. Int J Cancer (2002) 1.03
In vitro pharmacodynamics of 1-beta-D-arabinofuranosylcytosine: synergy of antitumor activity with cis-diamminedichloroplatinum(II). Cancer Res (1988) 0.97
Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer. Cancer Chemother Pharmacol (2007) 0.96
Assessment of celecoxib pharmacodynamics in pancreatic cancer. Mol Cancer Ther (2006) 0.92
Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco-2 cells. Int J Cancer (1997) 0.91
Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study. Ann Oncol (2006) 0.91
Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells. Gynecol Oncol (2003) 0.91
Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer. Clin Cancer Res (2011) 0.91
Intratumoral COX-2 gene expression is a predictive factor for colorectal cancer response to fluoropyrimidine-based chemotherapy. Clin Cancer Res (2005) 0.91
Inhibition of store-operated calcium entry contributes to the anti-proliferative effect of non-steroidal anti-inflammatory drugs in human colon cancer cells. Int J Cancer (2001) 0.90
Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy. Mol Cancer Ther (2007) 0.90
Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib. J Cancer Res Clin Oncol (2010) 0.88
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line. Mol Cell Endocrinol (2012) 0.86
Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate. Cancer Res (2000) 0.86
FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM). Ann Oncol (2006) 0.85
Efficacy of a nitric oxide-releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts. Mol Cancer Ther (2006) 0.84
Potential role of cyclooxygenase-2 on the regulation of the drug efflux transporter ABCG2 in breast cancer cell lines. J Cancer Res Clin Oncol (2010) 0.84
Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer. J Urol (2002) 0.81
Colon cancer cells with high invasive potential are susceptible to induction of apoptosis by a selective COX-2 inhibitor. Cancer Sci (2003) 0.81
Chebulagic acid synergizes the cytotoxicity of doxorubicin in human hepatocellular carcinoma through COX-2 dependant modulation of MDR-1. Med Chem (2011) 0.81
Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancer. Oncologist (2005) 0.79
Determination of celecoxib in human plasma by normal-phase high-performance liquid chromatography with column switching and ultraviolet absorbance detection. J Chromatogr B Biomed Sci Appl (2000) 0.78
Sequence-dependent effect of a cyclooxygenase-2 inhibitor on topoisomerase I inhibitor and 5-fluorouracil-induced cytotoxicity of colon cancer cells. Anticancer Drugs (2004) 0.77
The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature (2012) 11.91
De novo assembly and analysis of RNA-seq data. Nat Methods (2010) 9.69
A fast, high-endurance and scalable non-volatile memory device made from asymmetric Ta2O(5-x)/TaO(2-x) bilayer structures. Nat Mater (2011) 5.21
Alternative expression analysis by RNA sequencing. Nat Methods (2010) 5.02
Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2010) 4.51
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86
Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry (2004) 3.85
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol Cell (2008) 3.04
De novo genome sequence assembly of a filamentous fungus using Sanger, 454 and Illumina sequence data. Genome Biol (2009) 2.99
Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet (2002) 2.79
Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis. Blood (2003) 2.23
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res (2011) 2.09
Default mode network connectivity encodes clinical pain: an arterial spin labeling study. Pain (2012) 1.97
Iroquois homeobox gene 3 establishes fast conduction in the cardiac His-Purkinje network. Proc Natl Acad Sci U S A (2011) 1.92
Neural responses to happy facial expressions in major depression following antidepressant treatment. Am J Psychiatry (2007) 1.92
Disrupted brain circuitry for pain-related reward/punishment in fibromyalgia. Arthritis Rheumatol (2014) 1.89
Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients. Anesthesiology (2013) 1.86
Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion. Cancer Res (2008) 1.82
Organochlorines and risk of non-Hodgkin lymphoma. Int J Cancer (2007) 1.78
3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res (2002) 1.75
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol Biomarkers Prev (2008) 1.72
Proteomic analysis of the secretome of Leishmania donovani. Genome Biol (2008) 1.54
Epithelial and ectomesenchymal role of the type I TGF-beta receptor ALK5 during facial morphogenesis and palatal fusion. Dev Biol (2006) 1.50
Genome and transcriptome analyses of the mountain pine beetle-fungal symbiont Grosmannia clavigera, a lodgepole pine pathogen. Proc Natl Acad Sci U S A (2011) 1.50
A peptide of SPARC interferes with the interaction between caspase8 and Bcl2 to resensitize chemoresistant tumors and enhance their regression in vivo. PLoS One (2011) 1.48
Draft genome of the mountain pine beetle, Dendroctonus ponderosae Hopkins, a major forest pest. Genome Biol (2013) 1.46
Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res (2005) 1.44
Decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia. Arthritis Rheum (2012) 1.40
Effects of Cognitive-behavioral Therapy (CBT) on Brain Connectivity Supporting Catastrophizing in Fibromyalgia. Clin J Pain (2016) 1.40
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36
Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7. Proc Natl Acad Sci U S A (2012) 1.30
Physical electro-thermal model of resistive switching in bi-layered resistance-change memory. Sci Rep (2013) 1.30
ALEXA: a microarray design platform for alternative expression analysis. Nat Methods (2008) 1.23
Effective connectivity of a reward network in obese women. Brain Res Bull (2009) 1.23
The brain circuitry underlying the temporal evolution of nausea in humans. Cereb Cortex (2012) 1.22
Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging, and outcome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2004) 1.22
Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin. J Lipid Res (2008) 1.21
Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells. Clin Cancer Res (2004) 1.21
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. PLoS One (2011) 1.20
Brain encoding of acupuncture sensation--coupling on-line rating with fMRI. Neuroimage (2009) 1.15
Transcriptome and full-length cDNA resources for the mountain pine beetle, Dendroctonus ponderosae Hopkins, a major insect pest of pine forests. Insect Biochem Mol Biol (2012) 1.13
Time-variant fMRI activity in the brainstem and higher structures in response to acupuncture. Neuroimage (2009) 1.13
In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. Eur J Pharmacol (2004) 1.13
The ferritin Fe2 site at the diiron catalytic center controls the reaction with O2 in the rapid mineralization pathway. Proc Natl Acad Sci U S A (2008) 1.12
A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy. Biol Psychiatry (2007) 1.11
Robotic versus Laparoscopic versus Open Gastrectomy: A Meta-Analysis. J Gastric Cancer (2013) 1.11
Novel antioxidant ameliorates the fibrosis and inflammation of cerulein-induced chronic pancreatitis in a mouse model. Pancreatology (2005) 1.09
Palatal fusion - where do the midline cells go? A review on cleft palate, a major human birth defect. Acta Histochem (2006) 1.09
Fungal mycoflora and mycotoxins in Korean polished rice destined for humans. Int J Food Microbiol (2005) 1.09
The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model. Clin Cancer Res (2004) 1.08
Modeling for multilevel switching in oxide-based bipolar resistive memory. Nanotechnology (2012) 1.08
Current trends in the epidemiological and pathological characteristics of gastrointestinal stromal tumors in Korea, 2003-2004. J Korean Med Sci (2010) 1.08
Changes in regional gray matter volume in women with chronic pelvic pain: a voxel-based morphometry study. Pain (2012) 1.08
Mammaglobin expression in lymph nodes is an important marker of metastatic breast carcinoma. Arch Pathol Lab Med (2003) 1.07
Brain correlates of phasic autonomic response to acupuncture stimulation: an event-related fMRI study. Hum Brain Mapp (2012) 1.07
Neural crest cell-specific deletion of Rac1 results in defective cell-matrix interactions and severe craniofacial and cardiovascular malformations. Dev Biol (2010) 1.06
Protective effects of methyl gallate on H2O2-induced apoptosis in PC12 cells. Biochem Biophys Res Commun (2010) 1.06
A novel interaction between procaspase 8 and SPARC enhances apoptosis and potentiates chemotherapy sensitivity in colorectal cancers. J Biol Chem (2007) 1.06
Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling. Planta Med (2005) 1.04
Using partial correlation to enhance structural equation modeling of functional MRI data. Magn Reson Imaging (2007) 1.02
Helicobacter pylori infection promotes gastric carcinogenesis in a mice model. J Gastroenterol Hepatol (2002) 1.01
Static and dynamic autonomic response with increasing nausea perception. Aviat Space Environ Med (2011) 1.01
Identification of occupational cancer risks in British Columbia: a population-based case-control study of 1129 cases of bladder cancer. J Occup Environ Med (2005) 1.01
Comparison of Behcet's disease and recurrent aphthous ulcer according to characteristics of gastrointestinal symptoms. J Korean Med Sci (2005) 1.01
Extraskeletal chondroma of the fallopian tube. J Korean Med Sci (2002) 1.01
Structural basis for the inhibition of Mycobacterium tuberculosis L,D-transpeptidase by meropenem, a drug effective against extensively drug-resistant strains. Acta Crystallogr D Biol Crystallogr (2013) 1.00
Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability. Biochim Biophys Acta (2008) 1.00
Learning-induced enduring changes in functional connectivity among prefrontal cortical neurons. J Neurosci (2007) 1.00
Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer. J Cardiothorac Surg (2013) 0.99
Innate immune control of EBV-infected B cells by invariant natural killer T cells. Blood (2013) 0.99
The novel proteasome inhibitor BSc2118 protects against cerebral ischaemia through HIF1A accumulation and enhanced angioneurogenesis. Brain (2012) 0.99
Panax ginseng induces human Type I collagen synthesis through activation of Smad signaling. J Ethnopharmacol (2006) 0.99
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet (2013) 0.99
The EphA8 receptor induces sustained MAP kinase activation to promote neurite outgrowth in neuronal cells. Oncogene (2005) 0.98
Regulation of EphA8 gene expression by TALE homeobox transcription factors during development of the mesencephalon. Mol Cell Biol (2006) 0.97
Reduced telomere length variation in healthy oldest old. Mech Ageing Dev (2008) 0.97
Disentangling linear and nonlinear brain responses to evoked deep tissue pain. Pain (2012) 0.95
Asiaticoside induces human collagen I synthesis through TGFbeta receptor I kinase (TbetaRI kinase)-independent Smad signaling. Planta Med (2006) 0.95
Application of an entropy-based Bayesian optimization technique to the redesign of an existing monitoring network for single air pollutants. J Environ Manage (2009) 0.95
Preoperative serum CYFRA 21-1 level as a prognostic factor in surgically treated adenocarcinoma of lung. Lung Cancer (2012) 0.94
A mid-term follow-up result of spinopelvic fixation using iliac screws for lumbosacral fusion. J Korean Neurosurg Soc (2010) 0.92
Lasp anchors the Drosophila male stem cell niche and mediates spermatid individualization. Mech Dev (2008) 0.92
Genetic variation in healthy oldest-old. PLoS One (2009) 0.92
Interaction between organochlorines and the AHR gene, and risk of non-Hodgkin lymphoma. Cancer Causes Control (2009) 0.92
Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact. Microb Drug Resist (2012) 0.91
Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer. Clin Cancer Res (2011) 0.91
Igf Signaling is Required for Cardiomyocyte Proliferation during Zebrafish Heart Development and Regeneration. PLoS One (2013) 0.91
Prostate cancer risk and exposure to pesticides in British Columbia farmers. Prostate (2010) 0.91
Endoscopic third ventriculostomy: predicting outcome with phase-contrast MR imaging. Radiology (2009) 0.90
Cancer risk in aluminum reduction plant workers (Canada). Cancer Causes Control (2006) 0.90
The single IgG IL-1-related receptor controls TLR responses in differentiated human intestinal epithelial cells. J Immunol (2010) 0.90
Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy. Mol Cancer Ther (2007) 0.90